APA (7th ed.) Citation

Siepen, F. a. d., Hein, S., Hofmann, E., Nagel, C., Schwarting, S. K., Hegenbart, U., . . . Kristen, A. (2024). Prognostic value of standard heart failure medication in patients with cardiac transthyretin amyloidosis. Journal of Clinical Medicine, 13(8), . https://doi.org/10.3390/jcm13082257

Chicago Style (17th ed.) Citation

Siepen, Fabian aus dem, et al. "Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis." Journal of Clinical Medicine 13, no. 8 (2024). https://doi.org/10.3390/jcm13082257.

MLA (9th ed.) Citation

Siepen, Fabian aus dem, et al. "Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis." Journal of Clinical Medicine, vol. 13, no. 8, 2024, https://doi.org/10.3390/jcm13082257.